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SUMMARY. The aim of this research was to evaluate the effect of the angiotensin converting enzyme
(ACE) inhibitor fosinopril on liver fibrosis in rats with high fat diet (HFD) induced nonalcoholic steato-
hepatitis (NASH). We found that treatment with fosinopril improved liver fibrosis. Moreover, treatment
with fosinopril decreased serum Angiotensin (Ang) II, leptin, transforming growth factor β1 and
hyaluronic acid concentrations, increased serum ACE2, Ang-(1-7), and adiponectin concentrations in rats
fed with HFD. In the liver, fosinopril led to decreased leptin, α-smooth muscle actin, and collagen I expres-
sion, increased ACE2 and adiponectin expression. In conclusion, Fosinopril improves liver fibrosis by up-
regulating ACE2/Ang-(1-7) axis activation in rats with HFD-induced NASH. Furthermore, fosinopril
might regulate the progression of liver fibrosis through the downregulation of leptin and the upregulation
of adiponectin.
